Debios Diagnostics

Pitch

Biotech & Therapeutics

The company develops FIBROKIT™, the first non-invasive urine test for the detection of renal fibrosis, with clinically validated accuracy comparable to biopsy. It enables earlier diagnosis of chronic kidney disease and improved patient follow-up, supporting more effective and personalised care.